Latest Breaking News On - Ipsos medtech - Page 1 : comparemela.com

/PRNewswire/ Nuance Pharma ("the Company") announces the completion of dosing for all HNVs in the Phase I clinical study of its novel Ketorolac for IV.

Hong kongMark lotterMelissa donnellyVicky linAsia pacificMarkg lotterIpsos medtechNuance pharma the companyNuance pharmaNeumentum incGreater chinaExecutive chairmanPostoperative periodDual wheelPublic relations managerNuance pharma limited